
Overview
Background
Hemamali Samaratunga MBBS (Hons) LRCP (London) MRCS (UK) FRCPA, FRCPath
- Specialist Anatomical Pathologist, Managing Director, Aquesta Specialised Uropathology
- Full Professor, University of Queensland Faculty of Medicine
- Visiting Medical Officer, Greenslopes Private Hospital
Hemamali graduated with honours from the University of Sri Lanka, Colombo Medical School and completed Pathology specialty training in Queensland. She held a number of consultant posts in both hospital and private practice. In 2008 she established Aquesta Uropathology which now provides diagnostic uropathology services to the majority of urologists in Queensland and Northern New South Wales. In addition to this she maintains a large second opinion consultation practice with requests obtained from throughout Australia and from overseas.
She is active in Genitourinary Pathology research with collaborators in Australia, USA, Canada, Karolinska Institute in Sweden and the Wellington School of Medicine in New Zealand. She held the position of Secretary of the International Society of Urological Pathology from 2015 to 2019.
She was a contributor to the 2004, 2015 and 2022 World Health Organization (WHO) books on Classification of Tumours: Pathology and Genetics of Tumours of the Urinary and Male Reproductive System. She participated in the 2015 revision of the WHO Tumour Classification in Zurich, Switzerland (4th edition) as member, Prostate Tumour Panel. She was a representative of the Expert Groups formulating structured reporting protocols for the Royal College Pathologists of Australasia on kidney, testis and prostate cancer and is currently chairperson of the structured reporting protocols for Genitourinary cancer. She is also currently the Convener for the RCPA Uropathology Quality Assurance Program.
Qualifications
MBBS (HONS) LRCP (London) MRCS (UK) FRCPA FRCPath
Current UQ Appointments
Academic Title-Professor
Non-UQ Appointments
2008 - current: Specialist Anatomical Pathologist & Managing Director, Aquesta Specialized Uropathology
2015 - Current: Visiting Medical Officer, Greenslopes Private Hospital
2003 - 2021: Visiting Medical Officer, Princess Alexandra Hospital
June 2001 - Oct 2008: Specialist Anatomical Pathologist, Sullivan Nicolaides Pathology, Brisbane
1993 - 1997: Specialist Anatomical Pathologist, Royal Brisbane Hospital
1998 - 2001: Senior Anatomical Pathologist, North Brisbane Hospitals Board
Research Interests
- Granular tumour necrosis
- Diagnosis of limited adenocarcinoma on prostate needle biopsy
- Ductal adenocarcinoma of prostate
- Mucinous adenocarcinoma of prostate
- Radical prostatectomy handling and reporting
- Micropapillary urothelial cancer
- Mimics of bladder cancer
Awards and other Esteem Indicators
2017 Admitted to Fellowship of the Royal College of Pathologists, London (FRC Path) for sustained excellence in published works
2022 Awarded the Grawitz Medal of the International Society of Urological Pathology for distinguished service to the discipline of Urological Pathology
2023 Author of the publication Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: Ten year data from the TROG 03.04 RADAR Trial. Pathology 54: 49- 54, awarded the prize of
Article of the Year by the Royal College of Pathologists of Australasia.
2024 Distinguished Fellowship Award of the Royal College Pathologists of Australasia
For distinguished service to the discipline of Urological Pathology
Keywords
Pathology, Genitourinary cancer, Prostate, Kidney, Urinary tract, Testis, Penis
Availability
- Professor Hemamali Samaratunga is:
- Available for supervision
Fields of research
Research impacts
She has over 320 scientific publications and has a Google Scholar H-index of 56 with 18150 citations. To date she has authored or co-authored 28 books, 21 book chapters and 274 peer-reviewed publications. Apart from her primary research activities Professor Samaratunga actively collaborates with other research groups and is a regular contributor - often as primary or senior author to international research consortia. One notable contribution has been her involvement in the development of artificial intelligence programs for the reporting of prostate cancer. In collaborative studies involving colleagues from the Netherlands, Sweden, Australia, New Zealand and the United States she was chosen to be one of three expert pathologists to review all cases, thus setting the gold standard for the diagnosis and grading of prostate cancer. These studies have been published in highly prestigious journals as noted in her CV. Importantly in comparative studies, the AI program informed by the findings of group of three pathologists that included Professor Samaratunga, outperformed all other AI programs.
Works
Search Professor Hemamali Samaratunga’s works on UQ eSpace
2019
Journal Article
Intraductal carcinoma of the prostate: a critical re-appraisal
Varma, Murali, Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali and Kristiansen, Glen (2019). Intraductal carcinoma of the prostate: a critical re-appraisal. Virchows Archiv, 474 (5), 525-534. doi: 10.1007/s00428-019-02544-6
2019
Journal Article
Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma
Ng, Keng Lim, Ellis, Robert J., Samaratunga, Hemamali, Morais, Christudas, Gobe, Glenda C. and Wood, Simon T. (2019). Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma. Translational Andrology and Urology, 8 (S2), S123-S137. doi: 10.21037/tau.2018.11.02
2019
Journal Article
The International Society of Urological Pathology Education web-a web-based system for training and testing of pathologists
Egevad, Lars, Delahunt, Brett, Samaratunga, Hemamali, Leite, Katia R. M., Efremovs, Gennady, Furusato, Bungo, Han, Ming, Jufe, Laura, Tsuzuki, Toyonori, Wang, Zhe, Hornblad, Jonas and Clements, Mark (2019). The International Society of Urological Pathology Education web-a web-based system for training and testing of pathologists. Virchows Archiv, 474 (5), 577-584. doi: 10.1007/s00428-019-02540-w
2019
Conference Publication
Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)
Fogel, Brent, Becherel, Olivier, Zeitlin, Scott, Samaratunga, Hemamali, Greaney, Jessica, Homer, Hayden and Lavin, Martin (2019). Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2). AAN 71st Annual Meeting, Philadelphia, PA United States, 4-10 May 2019. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1212/wnl.92.15_supplement.p4.7-003
2019
Conference Publication
Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)
Fogel, Brent, Becherel, Olivier, Zeitlin, Scott, Samaratunga, Hemamali, Greaney, Jessica, Homer, Hayden and Lavin, Martin (2019). Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2). 71st Annual Meeting of the American-Academy-of-Neurology (AAN), Philadelphia, PA, United States, 4-10 May 2019. Philadelphia, PA, United States: Lippincott Williams & Wilkins.
2019
Journal Article
Outcomes of primary lymph node staging of intermediate and high risk prostate cancer with 68Ga-PSMA positron emission tomography/computerized tomography compared to histological correlation of pelvic lymph node pathology
Yaxley, John W., Raveenthiran, Sheliyan, Nouhaud, François-Xavier, Samartunga, Hemamali, Yaxley, Anna J., Coughlin, Geoff, Delahunt, Brett, Egevad, Lars, McEwan, Louise and Wong, David (2019). Outcomes of primary lymph node staging of intermediate and high risk prostate cancer with 68Ga-PSMA positron emission tomography/computerized tomography compared to histological correlation of pelvic lymph node pathology. The Journal of Urology, 201 (4), 815-820. doi: 10.1097/JU.0000000000000053
2019
Conference Publication
Assessing accuracy of multiparametric MRI and prostatic fusion biopsy in small targets utility of a target, near-target and MRI-negative biopsy schema in 34 patients
Gianduzzo, T. D., Samaratunga, H. and Gianduzzo, T. R. J. (2019). Assessing accuracy of multiparametric MRI and prostatic fusion biopsy in small targets utility of a target, near-target and MRI-negative biopsy schema in 34 patients. Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Brisbane Australia, Apr 13-16, 2019. HOBOKEN: WILEY.
2019
Conference Publication
The role of multiparametric MRI apparent diffusion co-efficient (ADC) values in prostate cancer grading and staging in men with PIRADS 3-5 mpMRI lesions
Raveenthiran, S., Yaxley, J., Brown, N., Parkinson, R. and Samaratunga, H. (2019). The role of multiparametric MRI apparent diffusion co-efficient (ADC) values in prostate cancer grading and staging in men with PIRADS 3-5 mpMRI lesions. Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Brisbane Australia, Apr 13-16, 2019. HOBOKEN: WILEY.
2019
Journal Article
Evolution, controversies and the future of prostate cancer grading
Egevad, Lars, Delahunt, Brett, Yaxley, John and Samaratunga, Hemamali (2019). Evolution, controversies and the future of prostate cancer grading. Pathology International, 69 (2), 55-66. doi: 10.1111/pin.12761
2019
Journal Article
Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded
Samaratunga, Hemamali, Delahunt, Brett, Egevad, Lars, Srigley, John R., Billis, Athanase, Bostwick, David G., Camparo, Philippe, Cheng, Liang, Clouston, David, Denham, James, Furusato, Bungo, Hartmann, Arndt, Jufe, Laura, Kench, James, Kenwright, Diane N., Kristiansen, Glen, Leite, Katia R.M., MacLennan, Gregory T., Merrimen, Jennifer, Moch, Holger, Oxley, Jon, Pan, Chin-Chen, Paner, Gladell, Ro, Jae, Sesterhenn, Isabell A. M., Shanks, Jonathan, Thunders, Michelle, Tsuzuki, Toyonori, Wheeler, Thomas ... Varma, Murali (2019). Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded. Pathology, 52 (2), 192-196. doi: 10.1016/j.pathol.2019.11.001
2019
Journal Article
Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)
Becherel, Olivier J., Fogel, Brent L., Zeitlin, Scott I., Samaratunga, Hemamali, Greaney, Jessica, Homer, Hayden and Lavin, Martin F. (2019). Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2). Cerebellum, 18 (3), 448-456. doi: 10.1007/s12311-019-01012-w
2019
Journal Article
Datasets for the reporting of neoplasia of the testis: recommendations from the International Collaboration on Cancer Reporting
Berney, Dan M., Comperat, Eva, Feldman, Darren R., Hamilton, Robert J., Idrees, Muhammad T., Samaratunga, Hemamali, Tickoo, Satish K., Yilmaz, Asli and Srigley, John R. (2019). Datasets for the reporting of neoplasia of the testis: recommendations from the International Collaboration on Cancer Reporting. Histopathology, 74 (1), 171-183. doi: 10.1111/his.13736
2019
Journal Article
Risk of metastatic disease on 68gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer
Yaxley, John W., Raveenthiran, Sheliyan, Nouhaud, François-Xavier, Samaratunga, Hemamali, Yaxley, William J., Coughlin, Geoff, Yaxley, Anna J., Gianduzzo, Troy, Kua, Boon, McEwan, Louise and Wong, David (2019). Risk of metastatic disease on 68gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer. BJU International, 124 (3), 401-407. doi: 10.1111/bju.14828
2019
Conference Publication
Design and clinical validation of surface enhanced Raman spectroscopy nanodiagnostic technology for urinary prostate cancer risk prediction
Gardiner, F., Koo, K., Wang, J., Richards, R., Farrell, A., Yaxley, J., Samaratunga, H., Teloken, P., Roberts, M., Coughlin, G., Lavin, M., Mainwaring, P., Wang, Y., Gardiner, R. and Trau, M. (2019). Design and clinical validation of surface enhanced Raman spectroscopy nanodiagnostic technology for urinary prostate cancer risk prediction. Annual Scientific Meeting of the Urological Society of Australia and New-Zealand, Brisbane, QLD Australia, 13-16 April 2019. Chichester, West Sussex United Kingdom: Wiley-Blackwell.
2019
Journal Article
Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma
Dagher, Julien, Delahunt, Brett, Rioux-Leclercq, Nathalie, Egevad, Lars, Coughlin, Geoff, Dunglison, Nigel, Gianduzzo, Troy, Kua, Boon, Malone, Greg, Martin, Ben, Preston, John, Pokorny, Morgan, Wood, Simon and Samaratunga, Hemamali (2019). Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma. Histopathology, 74 (2), 284-290. doi: 10.1111/his.13737
2019
Journal Article
Grading of renal cell carcinoma
Delahunt, Brett, Eble, John N., Egevad, Lars and Samaratunga, Hemamali (2019). Grading of renal cell carcinoma. Histopathology, 74 (1), 4-17. doi: 10.1111/his.13735
2019
Journal Article
Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma
Dagher, Julien, Delahunt, Brett, Rioux-Leclercq, Nathalie, Egevad, Lars, Varma, Murali and Samaratunga, Hemamali (2019). Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma. Pathology, 51 (4), 349-352. doi: 10.1016/j.pathol.2019.01.004
2018
Journal Article
Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker
Sina, Abu Ali Ibn, Carrascosa, Laura G., Liang, Ziyu, Grewal, Yadveer S., Wardiana, Andri, Shiddiky, Muhammad J. A., Gardiner, Robert A., Samaratunga, Hemamali, Gandhi, Maher K., Scott, Rodney J., Korbie, Darren and Trau, Matt (2018). Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker. Nature Communications, 9 (1) 4915, 4915. doi: 10.1038/s41467-018-07214-w
2018
Journal Article
The current status of renal cell carcinoma and prostate carcinoma grading
Delahunt, Brett, Egevad, Lars, Yaxley, John and Samaratunga, Hemamali (2018). The current status of renal cell carcinoma and prostate carcinoma grading. International Braz J Urol, 44 (6), 1057-1062. doi: 10.1590/S1677-5538.IBJU.2018.06.01
2018
Journal Article
MRI-guided in-bore biopsy for prostate cancer: what does the evidence say?: a case series of 554 patients and a review of the current literature
Pokorny, Morgan, Kua, Boon, Esler, Rachel, Yaxley, John, Samaratunga, Hemamali, Dunglison, Nigel, Gianduzzo, Troy, Coughlin, Geoff, Holt, Ross, Laing, Barbara, Ault, Darren, Brown, Nicholas, Parkinson, Rob and Thompson, Les (2018). MRI-guided in-bore biopsy for prostate cancer: what does the evidence say?: a case series of 554 patients and a review of the current literature. World Journal of Urology, 37 (7), 1263-1279. doi: 10.1007/s00345-018-2497-y
Supervision
Availability
- Professor Hemamali Samaratunga is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Completed supervision
-
2020
Doctor Philosophy
Exploring Resistance of Renal Cell Carcinoma to Sunitinib Therapy
Associate Advisor
Other advisors: Associate Professor David Vesey
-
2019
Doctor Philosophy
Cellular and molecular mechanisms of pancreatitis in atrophy and regeneration
Associate Advisor
Media
Enquiries
For media enquiries about Professor Hemamali Samaratunga's areas of expertise, story ideas and help finding experts, contact our Media team: